FLSM
NBRV

Frazier Life Sciences Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Frazier Life Sciences Management’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,025
Closed -$29.7K – 53
2023
Q1 		$29.7K Hold
17,025
– – ﹤0.01% 49
2022
Q4 		$32.2K Hold
17,025
– – ﹤0.01% 44
2022
Q3 		$35K Sell
17,025
-1
-0% -$4 ﹤0.01% 43
2022
Q2 		$77K Hold
17,026
– – 0.01% 41
2022
Q1 		$179K Buy
+17,026
New +$207K 0.02% 42

Other funds holding NBRV

VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $569M AUM 21.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
AA
Addison Advisors Middlebury, Vermont $452M AUM 14.62% 1-Year Est. Return